vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and Rhinebeck Bancorp, Inc. (RBKB). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $13.5M, roughly 1.1× Rhinebeck Bancorp, Inc.). On growth, Rhinebeck Bancorp, Inc. posted the faster year-over-year revenue change (1701.1% vs -69.7%). Over the past eight quarters, Rhinebeck Bancorp, Inc.'s revenue compounded faster (14.0% CAGR vs 11.9%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Rhinebeck Bancorp, Inc. is a US regional bank holding company based in New York. It operates Rhinebeck Bank, offering retail and commercial banking services including deposit accounts, loans, mortgages and wealth management, mainly serving consumers and small-to-medium businesses across New York's Hudson Valley region.

IRIX vs RBKB — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.1× larger
IRIX
$14.7M
$13.5M
RBKB
Growing faster (revenue YoY)
RBKB
RBKB
+1770.8% gap
RBKB
1701.1%
-69.7%
IRIX
Faster 2-yr revenue CAGR
RBKB
RBKB
Annualised
RBKB
14.0%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
RBKB
RBKB
Revenue
$14.7M
$13.5M
Net Profit
$2.3M
Gross Margin
37.2%
Operating Margin
21.7%
Net Margin
17.3%
Revenue YoY
-69.7%
1701.1%
Net Profit YoY
188.0%
EPS (diluted)
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
RBKB
RBKB
Q4 25
$14.7M
$13.5M
Q3 25
$12.5M
$14.0M
Q2 25
$13.6M
$13.1M
Q1 25
$11.9M
$12.8M
Q4 24
$12.7M
$750.0K
Q3 24
$11.6M
$773.0K
Q2 24
$12.6M
$10.7M
Q1 24
$11.8M
$10.4M
Net Profit
IRIX
IRIX
RBKB
RBKB
Q4 25
$2.3M
Q3 25
$-1.6M
$2.7M
Q2 25
$-994.0K
$2.7M
Q1 25
$-1.7M
$2.3M
Q4 24
$-834.0K
$-2.7M
Q3 24
$-1.9M
$-8.1M
Q2 24
$-2.7M
$975.0K
Q1 24
$-3.5M
$1.1M
Gross Margin
IRIX
IRIX
RBKB
RBKB
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
RBKB
RBKB
Q4 25
21.7%
Q3 25
-11.3%
23.9%
Q2 25
-6.9%
26.6%
Q1 25
-1.7%
22.9%
Q4 24
-3.9%
-444.9%
Q3 24
-16.1%
-1332.3%
Q2 24
-20.9%
11.8%
Q1 24
-28.0%
13.9%
Net Margin
IRIX
IRIX
RBKB
RBKB
Q4 25
17.3%
Q3 25
-12.6%
19.3%
Q2 25
-7.3%
20.8%
Q1 25
-14.2%
17.9%
Q4 24
-6.6%
-353.9%
Q3 24
-16.7%
-1042.9%
Q2 24
-21.2%
9.2%
Q1 24
-29.5%
10.8%
EPS (diluted)
IRIX
IRIX
RBKB
RBKB
Q4 25
$0.21
Q3 25
$-0.09
$0.25
Q2 25
$-0.06
$0.25
Q1 25
$-0.10
$0.21
Q4 24
$-0.05
$-0.24
Q3 24
$-0.12
$-0.75
Q2 24
$-0.16
$0.09
Q1 24
$-0.21
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
RBKB
RBKB
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$136.9M
Total Assets
$29.2M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
RBKB
RBKB
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
RBKB
RBKB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
RBKB
RBKB
Q4 25
$136.9M
Q3 25
$4.7M
$133.0M
Q2 25
$6.1M
$129.0M
Q1 25
$852.0K
$126.0M
Q4 24
$2.1M
$121.8M
Q3 24
$2.6M
$122.7M
Q2 24
$4.2M
$116.2M
Q1 24
$6.5M
$114.3M
Total Assets
IRIX
IRIX
RBKB
RBKB
Q4 25
$29.2M
$1.3B
Q3 25
$28.4M
$1.3B
Q2 25
$31.6M
$1.3B
Q1 25
$34.2M
$1.3B
Q4 24
$29.1M
$1.3B
Q3 24
$30.2M
$1.3B
Q2 24
$31.2M
$1.3B
Q1 24
$34.1M
$1.3B
Debt / Equity
IRIX
IRIX
RBKB
RBKB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
RBKB
RBKB
Operating Cash FlowLast quarter
$11.7M
Free Cash FlowOCF − Capex
$10.9M
FCF MarginFCF / Revenue
80.6%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
5.03×
TTM Free Cash FlowTrailing 4 quarters
$19.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
RBKB
RBKB
Q4 25
$11.7M
Q3 25
$-1.2M
$2.2M
Q2 25
$-397.0K
$2.4M
Q1 25
$-1.1M
$4.3M
Q4 24
$-1.2M
$8.5M
Q3 24
$-3.1M
$-3.6M
Q2 24
$-1.3M
$12.0M
Q1 24
$-1.6M
$-3.5M
Free Cash Flow
IRIX
IRIX
RBKB
RBKB
Q4 25
$10.9M
Q3 25
$-1.2M
$2.0M
Q2 25
$-410.0K
$2.2M
Q1 25
$-1.2M
$4.2M
Q4 24
$-1.2M
$7.7M
Q3 24
$-3.1M
$-3.6M
Q2 24
$11.8M
Q1 24
$-1.7M
$-3.7M
FCF Margin
IRIX
IRIX
RBKB
RBKB
Q4 25
80.6%
Q3 25
-9.4%
14.5%
Q2 25
-3.0%
17.2%
Q1 25
-9.8%
32.8%
Q4 24
-9.8%
1023.9%
Q3 24
-26.5%
-469.0%
Q2 24
111.1%
Q1 24
-14.0%
-36.0%
Capex Intensity
IRIX
IRIX
RBKB
RBKB
Q4 25
6.3%
Q3 25
0.1%
1.4%
Q2 25
0.1%
1.4%
Q1 25
0.1%
0.9%
Q4 24
0.1%
105.5%
Q3 24
0.0%
6.3%
Q2 24
0.0%
1.2%
Q1 24
0.0%
2.3%
Cash Conversion
IRIX
IRIX
RBKB
RBKB
Q4 25
5.03×
Q3 25
0.83×
Q2 25
0.89×
Q1 25
1.89×
Q4 24
Q3 24
Q2 24
12.27×
Q1 24
-3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons